Pharmacokinetic Evaluation of Sustained Release Formulations of Antiepileptic Drugs
- 1 January 1992
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 22 (1) , 11-21
- https://doi.org/10.2165/00003088-199222010-00002
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Slow release carbamazepine in treatment of poorly controlled seizures.Archives of Disease in Childhood, 1990
- Diurnal Variation of Carbamazepine and Carbamazepine-10,11-epoxide in Plasma and Saliva in Children With Epilepsy: A Comparison Between Conventional and Slow-Release FormulationsJournal of Child Neurology, 1990
- Pharmacokinetic Study of a Slow-Release Preparation of Sodium Valproate (KW-6066N): Multiple Dose Administration Test and the Steady-State Serum Level Profiles in Epileptic PatientsPsychiatry and Clinical Neurosciences, 1989
- A comparison of carbamazepine divitabs with carbamazepine normal formulation in psychiatric and oligophrenic patientsInternational Journal of Clinical Pharmacy, 1989
- Clinical Monitoring During Carbamazepine Slow‐Release, Once‐Daily MonotherapyEpilepsia, 1988
- Controlled Release Carbamazepine: Cognitive Side Effects in Patients with EpilepsyEpilepsia, 1987
- Simultaneous First- and Zero-Order Absorption of Carbamazepine Tablets in HumansJournal of Pharmaceutical Sciences, 1986
- Interdosage Fluctuations in Plasma Carbamazepine Concentration Determine Intermittent Side EffectsArchives of Neurology, 1984
- Variability in Level‐Dose Ratio of Valproate: Monotherapy Versus PolytherapyEpilepsia, 1984
- Kinetic Analysis of Blood Levels and Urinary Excretion in the Absorptive Phase after Single Doses of DrugJournal of Pharmaceutical Sciences, 1964